Part of the Rosalie and Harold Rae Brown Center for Cancer Drug Development (CCDD) Seminar Series

Learn more about:

• Virtual Screening and Cheminformatics
• Machine Learning for Improving Permeability
• Structure-Based Design of BRD4 Inhibitors
• Structure-Based Design of METTL16 Inhibitors
• Ligand-Based Hit-to-Lead Optimization
• ChemDiv capabilities as a leading CRO in the area of medicinal chemistry

Speakers:
Rouslan Michtchenko, MBA
Senior Business Development Director, ChemDiv

and

Alexei Pushechnikov, PhD
Vice President, Discovery Platforms, ChemDiv

Register today: 

https://usc.zoom.us/meeting/register/tJUkceygpjwjHNDHFWaJt2LS2rY9Pw_0Ps0u